Knowledge & Resources
Global Innovative Contracting analysis, opinion and insights from our experts and global payer network
Navigating the Maze: A Guide to Evaluating Innovative Contracts in the Pharma Industry
While there’s ample discussion around the theory of innovative contracting and various case studies illustrating its successful implementation globally, accurately measuring the impact of these agreements remains a relatively uncharted territory…
Is VBP the new VBC for U.S. Drug Prices?
All U.S. healthcare stakeholders recognize that the overheated drugs market is not sustainable. The ever-growing spiral of rising gross prices, often accompanied by increasing rebates and returns, is not a model fit for purpose now, let alone the future.
Value-based Agreements deliver U.S. Patient and Caregiver Benefits: New Evidence
National and regional payers identify the real-world advantages of innovative contracts